Correlation Between Recursion Pharmaceuticals and Black Diamond
Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and Black Diamond at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and Black Diamond into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Recursion Pharmaceuticals and Black Diamond Therapeutics, you can compare the effects of market volatilities on Recursion Pharmaceuticals and Black Diamond and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of Black Diamond. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and Black Diamond.
Diversification Opportunities for Recursion Pharmaceuticals and Black Diamond
0.05 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Recursion and Black is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and Black Diamond Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Black Diamond Therap and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with Black Diamond. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Black Diamond Therap has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and Black Diamond go up and down completely randomly.
Pair Corralation between Recursion Pharmaceuticals and Black Diamond
Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 9.03 times less return on investment than Black Diamond. But when comparing it to its historical volatility, Recursion Pharmaceuticals is 1.33 times less risky than Black Diamond. It trades about 0.03 of its potential returns per unit of risk. Black Diamond Therapeutics is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest 214.00 in Black Diamond Therapeutics on November 3, 2024 and sell it today you would earn a total of 48.00 from holding Black Diamond Therapeutics or generate 22.43% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Recursion Pharmaceuticals vs. Black Diamond Therapeutics
Performance |
| Timeline |
| Recursion Pharmaceuticals |
| Black Diamond Therap |
Recursion Pharmaceuticals and Black Diamond Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Recursion Pharmaceuticals and Black Diamond
The main advantage of trading using opposite Recursion Pharmaceuticals and Black Diamond positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, Black Diamond can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Black Diamond will offset losses from the drop in Black Diamond's long position.| Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
| Black Diamond vs. Passage Bio | Black Diamond vs. Alector | Black Diamond vs. Revolution Medicines | Black Diamond vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |